Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top new orphan molecular entities by U.S. sales in 2019

Leading new orphan molecular entities by U.S. sales in 2014 and 2019 (in million U.S. dollars)*

by Statista Research Department, last edited Oct 30, 2015
Top new orphan molecular entities by U.S. sales in 2019 This statistic displays a projection of the top orphan molecular entities (approved in 2014) based on projected U.S. consensus sales in 2019. Biogen's Eloctate was approved in June 2014 and generated 58 million U.S. dollars in revenue during the same year in the United States. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
Show more

Leading new orphan molecular entities by U.S. sales in 2014 and 2019 (in million U.S. dollars)*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in the Netherlands"
  • Industry overview
The most important statistics
  • Dispensed medicines
  • Self-care medication
  • Pharmacies
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.